spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  TAXUS Express2 

 HSMN NewsFeed - 20 May 2010
Boston Scientific Announces Schedule for EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2009
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2009
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 May 2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2009
Boston Scientific Announces Schedule For ACC 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jan 2009
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Oct 2008
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Oct 2008
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Sep 2008
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 1 Sep 2008
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 27 May 2008
Medtronic Awarded $250 Million Damages in Patent Case against Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 13 May 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jun 2007
Positive Results for Second-Generation Taxus(R) Liberte(TM) Coronary Stent System Highlighted in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
TAXUS VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2007
Boston Scientific Announces Schedule for EuroPcr 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2007
Boston Scientific Announces Japanese Launch of TAXUS(R) Express2(TM) Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Apr 2007
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Apr 2007
Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 3 Apr 2007
Boston Scientific Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Mar 2007
Boston Scientific Announces Schedule for ACC 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2007
Boston Scientific Comments on Swedish Registry Results
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Excellent Deliverability and Proven Outcomes of TAXUS(R) Liberté(TM) stent system
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Moderate-Release TAXUS(R) Express(TM) Coronary Stent System Demonstrates Sustained Long-Term Outcomes in High-Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2006
Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 29 additional stories matching:
TAXUS Express2
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.